Navigation Links
TRU-D Tested in Most Comprehensive UV Disinfection Study to Date
Date:8/14/2014

DURHAM, N.C., Aug. 14, 2014 /PRNewswire/ -- This past week, a groundbreaking 28-month-long study funded by Centers for Disease Control and Prevention examining the real-world effectiveness of automated UV-C disinfection robot's impact on infection outcomes concluded the data collection phase of the research, with results expected to be published in the second quarter of 2015.

The study by the Duke University Prevention Epicenter Program, "The Benefits of Enhanced Terminal Room (BETR) Disinfection," is the most comprehensive research assessing automated UV-C disinfection completed to date and will present outcomes related to clostridium difficile (C. diff.), methicillin-resistant staphylococcus aureus (MRSA), multidrug-resistant acinetobacter baumanni and vancomycin-resistant enterococci.

Infection control researchers from Duke University Medical Center in Durham, North Carolina, and The University of North Carolina at Chapel Hill, have been collecting data across 10 hospitals and 25,000 disinfection cycles for more than 100,000 patient days to determine how UV-C emitting devices capable of measuring a specific UVC dose may improve patient outcomes and the quality of care. TRU-D SmartUVC was the UV disinfection device of choice for the team of researchers and was the sole device used during the study, academic teaching hospital, tertiary care centers, community hospitals and a VA Medical Center.

Previous reports released from the study point to the effectiveness of TRU-D for patient rooms that are disinfected using the robot, as the researchers have seen more than 90 percent of pathogenic bacteria eradicated using only TRU-D with no manual pre-cleaning. In addition, they have determined that devices without patented intuitive technology, like TRU-D's Sensor360, place hospitals at a significant risk of under- or overestimating the time necessary to properly disinfect patient rooms, resulting inconsistent results, or worse, increased risk of hospital-acquired infection contraction by patients from infected rooms.

"TRU-D's intuitive technology has been validated by more than 10 studies prior to this CDC funded research, so we are confident that it will continue to meet that expectation in this study, as well," said Chuck Dunn, president of TRU-D LLC. "Most of all, we are eager to use the results of this study to continue enhancement of TRU-D so it remains the most innovative and advanced automated UV-C disinfection product available to infection prevention teams."

Since it first entered the market, TRU-D has offered the only automated portable UV-C emitting disinfection system with Sensor360 technology, allowing to precisely calculate room UVC dose to compensate for room size, shape, color and contents for proper thorough disinfection of health care environments. Recently, TRU-D became an even more valuable asset to infection preventionists, as the robot now comes standard with innovative technology that instantaneously collects and reports disinfection data with its secure cloud-based tracking system, iTRU-D. Customized reports are uploaded to a private portal, which allows hospital's infection prevention teams to assess real-time infection prevention results, usage efficiency and risk-aversion data.

TRU-D SmartUVC is the device of choice for nearly all existing independent research on UV disinfection technology and has been utilized in 10 third-party studies. More than 200 TRU-Ds have been deployed to disinfect hospitals across the U.S., Canada and Europe including the National Institutes of Health Clinical Center in Bethesda, Maryland; the Ralph H. Johnson VA Medical Center in Charleston, South Carolina; and Houston Methodist in Houston, Texas. For information and links to independent studies on TRU-D, visit www.TRU-D.com.

For more information, contact:
Lauren Hannaford                                
Obsidian Public Relations                      
Phone: 901-572-1042                
Email 


'/>"/>
SOURCE TRU-D
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. TRU-D SmartUVC Sales Soar in 2013 with Increased Acceptance of Proven Infection Prevention Technology
2. Groundbreaking UK Study Confirms Significant Reduction in Hospital Superbug Pathogens with TRU-D SmartUVC Disinfection Robot
3. Lumalier Helps Hospitals Improve Infection Control Efforts with Real-time Disinfection Data from New iTRU-D Technology and Web Portal System
4. New UV-C-Reflective Wall Coating Dramatically Reduces Disinfection Times for TRU-D Device
5. Anne Arundel Medical Center to Improve Patient Safety with Superbug-Slaying Robot TRU-D
6. Vancouver General Hospital Deploys TRU-D Superbug Slayer to Battle Worst Season of Flu in Recent Memory
7. Embrace Life and Hear the Joy This Holiday Season, Get Your Hearing Tested with a Loved One, BHI Urges
8. CIM med: Carrier Arms to Connect Anesthesia Machines now TÜV-Tested
9. FDA approves drug tested by Scottsdale Healthcare and TGen
10. Baby Boomers Should Get Tested for Hepatitis C
11. PDA Comprehensive Course Series Addresses Need for Aseptic Process Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... -- Did you know that PhRMA member companies invested $65.5 billion ... on brand medicines, generics and the supply chain account for 14 ... half of this (7 percent)? Or that the United ... capital investments in high-growth biopharmaceutical startups? ... The biopharmaceutical industry ...
(Date:7/15/2017)... 15, 2017 Enterin Inc., a Philadelphia ... disease (PD), today announced the completion of a $12.7 million ... Ventures III, as well as the participation of existing investors. ... to have the support of New Ventures III and our ... validation of the potential of our platform technology to transform ...
(Date:7/13/2017)... -- RK Logistics Group, Inc. was awarded California ... Fremont, CA headquarters facility where it provides ... San Jose for hi-tech, pharmaceutical and biomedical ... with its Fremont Innovation District, is excited to strategically partner ... to the hundreds of biotech, pharma and biomed companies throughout ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... The Visiting ... the C. R. Bard Foundation, Inc. to support the music therapy ... service available through the nonprofit home care agency. Using evidence-based methods, professionally trained ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon Kleyne is ... product of her research center at Bio-Logic Aqua Research® Water Life Science®, has ... greatest number of sufferers of blindness. “We think that Nature’s Tears® EyeMist® will ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... cruciate ligament (ACL) offer patients improved quality of life five years after injury, ... Medicine’s Annual Meeting in Toronto, Ontario, Canada. The study followed patients for ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... in Houston, is pleased to announce their expansion to the Midwest with the ... directors Alysse Hollis and Ronald Bell, and of counsels, John Peck and Robert ...
Breaking Medicine News(10 mins):